* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Reference:
[1] Recueil des Travaux Chimiques des Pays-Bas, 1951, vol. 70, p. 182,190
2
[ 16867-04-2 ]
[ 19365-08-3 ]
Reference:
[1] Acta Chemica Scandinavica (1947-1973), 1957, vol. 11, p. 914
[2] Zeitschrift fuer Naturforschung, B: Chemical Sciences, 1987, vol. 42, # 6, p. 785 - 790
3
[ 98-01-1 ]
[ 613-75-2 ]
[ 16867-04-2 ]
Reference:
[1] Tohoku J.agric.Res., 1954, vol. 5, p. 147,150[2] Chem.Abstr., 1956, p. 4941
4
[ 109-00-2 ]
[ 16867-04-2 ]
[ 10182-48-6 ]
Reference:
[1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1993, vol. 29, # 6, p. 730 - 731[2] Khimiya Geterotsiklicheskikh Soedinenii, 1993, # 6, p. 847 - 848
5
[ 63756-60-5 ]
[ 16867-04-2 ]
Reference:
[1] Chemische Berichte, 1928, vol. 61, p. 1028
6
[ 109-00-2 ]
[ 6602-28-4 ]
[ 16867-04-2 ]
[ 10182-48-6 ]
Reference:
[1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1993, vol. 29, # 6, p. 730 - 731[2] Khimiya Geterotsiklicheskikh Soedinenii, 1993, # 6, p. 847 - 848
7
[ 142-08-5 ]
[ 16867-04-2 ]
Reference:
[1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1985, vol. 24, p. 972 - 973
8
[ 89694-54-2 ]
[ 16867-04-2 ]
[ 6636-78-8 ]
Reference:
[1] Recueil des Travaux Chimiques des Pays-Bas, 1951, vol. 70, p. 182,190
9
[ 63430-18-2 ]
[ 16867-04-2 ]
Reference:
[1] Nippon Nogei Kagaku Kaishi, 1940, vol. 16, p. 249,253, 264[2] Chem.Abstr., 1940, p. 6278,6940
[3] Nippon Nogei Kagaku Kaishi, 1940, vol. 16, p. 249,253, 264[4] Chem.Abstr., 1940, p. 6278,6940
10
[ 13472-83-8 ]
[ 16867-04-2 ]
Reference:
[1] Chemische Berichte, 1936, vol. 69, p. 2593,2604
Reference:
[1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1985, vol. 24, p. 972 - 973
13
[ 109-00-2 ]
[ 16867-04-2 ]
Reference:
[1] Chemische Berichte, 1936, vol. 69, p. 2593,2604
14
[ 40263-57-8 ]
[ 16867-04-2 ]
Reference:
[1] Chemische Berichte, 1936, vol. 69, p. 2593,2604
15
[ 861019-58-1 ]
[ 16867-04-2 ]
Reference:
[1] Nippon Nogei Kagaku Kaishi, 1940, vol. 16, p. 249,253, 264[2] Chem.Abstr., 1940, p. 6278,6940
16
[ 324028-89-9 ]
[ 16867-04-2 ]
Reference:
[1] Nippon Nogei Kagaku Kaishi, 1940, vol. 16, p. 249,253, 264[2] Chem.Abstr., 1940, p. 6278,6940
17
[ 109-00-2 ]
[ 16867-04-2 ]
[ 10182-48-6 ]
Reference:
[1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1993, vol. 29, # 6, p. 730 - 731[2] Khimiya Geterotsiklicheskikh Soedinenii, 1993, # 6, p. 847 - 848
18
[ 109-00-2 ]
[ 6602-28-4 ]
[ 16867-04-2 ]
[ 10182-48-6 ]
Reference:
[1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1993, vol. 29, # 6, p. 730 - 731[2] Khimiya Geterotsiklicheskikh Soedinenii, 1993, # 6, p. 847 - 848
19
[ 16867-04-2 ]
[ 106-93-4 ]
[ 129421-32-5 ]
Yield
Reaction Conditions
Operation in experiment
5.7%
With potassium carbonate In N,N-dimethyl-formamide at 20 - 90℃;
a-1) Preparation of 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine2,3-Dihydroxypyridine (2.22 g, 20.0 mmol) was dissolved in N,N'-dimethylformamide (100 mL), and added potassium carbonate (5.52 g, 40.0 mmol) at room temperature. 5 minutes after, 1,2-dibromoethane (2.6 mL, 30.0 mmol) was added at the same temperature, and stirred at 90° C. overnight. The reaction solution was reverted to room temperature, filtered, and the obtained filtrate was concentrated in vacuo. Then, the obtained residue was added ethyl acetate. The suspension was filtered, washed ethyl acetate, and concentrated in vacuo. The title compound (157 mg (yield 5.7percent)) was obtained as a colorless oil.1H-NMR (CDCl3) δ: 4.26-4.28 (2H, m), 4.42-4.44 (2H, m), 6.94 (1H, dd, J=5.6, 7.6 Hz), 7.28 (1H, dd, J=1.2, 7.6 Hz), 7.69 (1H, dd, J=1.2, 5.6 Hz).
With sodium t-butanolate In methanol at 100℃; for 0.333333 h; Irradiation
To a solution of 2,3-dihydroxypyridine (5.0 g, 45.0 mmol, 1.0 equiv) and sodium tert-butoxide (4.33 g, 45.0 mmol, 1.0 equiv) in methanol (25 mL) was added ethyl iodide (5.21 mL, 7.72 g, 49.5 mmol, 1.1 equiv) and the reaction mixture heated to 100° C. under microwave irradiation for 20 min. The solvent was removed and the reaction product dissolved in dichloromethane (50 mL), the obtained suspension filtered and the organic phase concentrated by evaporation under reduced pressure. The crude material was purified by column chromatography on silica eluting with dichloromethane/methanol (9:1) yielding 3.0 g (41percent) of the title compound. 1H NMR (300 MHz, CDCl3): δ 1.50 (t, J=7.0 Hz, 3H), 4.05 (q, J=7.0 Hz, 2H), 6.20 (t, J=7.1 Hz, 1H), 6.76 (dd, J=7.4 Hz, J=1.3 Hz, 1H), 7.05 (dd, J=6.5 Hz, J=1.3 Hz, 1H), 13.36 (br s, 1H).
Stage #1: dihydroxypyridine With sodium hydroxide In water at 0℃; for 0.25h;
Stage #2: dimethyl sulfate In water at 20℃; for 3h;
89 Example 89: N-(4-((2-((5-cyclopropyl-1-methyl-2-oxo- 1,2-dihydropyridin-3 -yl)oxy)-1-methyl-1H-benzo[d]imidazol-6-yl)oxy)pyridin-2-yl)acetamide
[0634] Synthesis of compound 89.2. To a 1 M aqueous solution of sodium hydroxide (51 mL, 135 mmol, 1.0 equiv) at 0 °C was added 89.1 (15 g, 135 mmol, 1.0 equiv). After 15 min dimethyl sulfate (12.8 mL, 135 mmol, 1.0 equiv) was added at 0 °C. The reaction mixture was stirred at room temperature for 3 h. It was neutralized with acetic acid to pH 7 and extracted with dichloromethane. The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by flash column chromatography on silica gel (CombiFlash, 3.2% methanol in dichloromethane as eluant) to afford 89.2. MS (ES): m/z 126.2 [M+H]+.
With sodium t-butanolate; In methanol; at 100℃; for 0.333333h;Irradiation;
To a solution of 2,3-dihydroxypyridine (5.0 g, 45.0 mmol, 1.0 equiv) and sodium tert-butoxide (4.33 g, 45.0 mmol, 1.0 equiv) in methanol (25 mL) was added ethyl iodide (5.21 mL, 7.72 g, 49.5 mmol, 1.1 equiv) and the reaction mixture heated to 100 C. under microwave irradiation for 20 min. The solvent was removed and the reaction product dissolved in dichloromethane (50 mL), the obtained suspension filtered and the organic phase concentrated by evaporation under reduced pressure. The crude material was purified by column chromatography on silica eluting with dichloromethane/methanol (9:1) yielding 3.0 g (41%) of the title compound. 1H NMR (300 MHz, CDCl3): delta 1.50 (t, J=7.0 Hz, 3H), 4.05 (q, J=7.0 Hz, 2H), 6.20 (t, J=7.1 Hz, 1H), 6.76 (dd, J=7.4 Hz, J=1.3 Hz, 1H), 7.05 (dd, J=6.5 Hz, J=1.3 Hz, 1H), 13.36 (br s, 1H).
With potassium carbonate; In N,N-dimethyl-formamide; at 20 - 90℃;
a-1) Preparation of 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine2,3-Dihydroxypyridine (2.22 g, 20.0 mmol) was dissolved in N,N'-dimethylformamide (100 mL), and added potassium carbonate (5.52 g, 40.0 mmol) at room temperature. 5 minutes after, 1,2-dibromoethane (2.6 mL, 30.0 mmol) was added at the same temperature, and stirred at 90 C. overnight. The reaction solution was reverted to room temperature, filtered, and the obtained filtrate was concentrated in vacuo. Then, the obtained residue was added ethyl acetate. The suspension was filtered, washed ethyl acetate, and concentrated in vacuo. The title compound (157 mg (yield 5.7%)) was obtained as a colorless oil.1H-NMR (CDCl3) delta: 4.26-4.28 (2H, m), 4.42-4.44 (2H, m), 6.94 (1H, dd, J=5.6, 7.6 Hz), 7.28 (1H, dd, J=1.2, 7.6 Hz), 7.69 (1H, dd, J=1.2, 5.6 Hz).
With potassium carbonate; In dimethyl sulfoxide; at 100℃; for 10h;Inert atmosphere;
[000788] A mixture of Compound 185A (22.2 g, 200 mmol), 1 ,2-dibromoethane (55.8 g, 300 mmol), and K2C03 (55.2 g, 600 mmol) in DMSO (270 mL) was stirred at 100 C for 10 h under nitrogen protection. Then it was cooled to room temperature and extracted with ethyl acetate (100 mL x 3). The ethyl acetate layers were combined and washed with water (50 mL x 3) and brine (50 mL), dried over sodium sulfate, and concentrated to offer the title Compound 185B.